Dudediligence.

Akari Therapeutics, Plc

AKTXNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$2.9MSep ’24−$3.8MDec ’24−$3.7MMar ’25−$1.9MJun ’25−$6.4MSep ’25−$5.3MDec ’25−$14.5MMar ’26−$4.8MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating incomenone on file−$23.1M−$16.8M−$21.6M−$17.3M
Net incomenone on file−$17.7M−$10.0M−$19.8M−$17.3M
Operating cash flownone on file−$21.5M−$16.4M−$12.6M−$10.6M
Cash$9.4M$13.3M$3.8M$2.6M$5.2M
Shares outstandingnone on file7.44B13.23B53.19B90.54B